Rejoyn: First App Cleared by FDA for Depression; Cost, Efficacy Unclear
Year: 2024
Type: other
Source: Psychiatric News
Author: Linda M. Richmond
Language: English
Subfield: Applied Psychology
Field: Psychology
Domain: Social Sciences
Open Access status: closed
OpenAlex ID: W4397003537
